ArticleMicroorganisms2021
Microbial Communities of
Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 17 citations in OpenAlex.
- Deciphering the biosynthetic pathways of lichen acids.The New phytologist · 2026Article
- Mycobiomes of Six Lichen Species from the Russian Subarctic: A Culture-Independent Analysis and Cultivation Study.Journal of fungi (Basel, Switzerland) · 2025Article
- A reference metagenome sequence of the lichen Cladonia rangiformis.BMC biology · 2025Article
- A Biosynthetic and Taxonomic Atlas of the Global Lichen Holobiont.Environmental microbiology · 2025Article
- An Antarctic lichen isolate (Cladonia borealis) genome reveals potential adaptation to extreme environments.Scientific reports · 2024Article
- Article
- Unravelling Novel Phytochemicals and Anticholinesterase Activity in IrishMolecules (Basel, Switzerland) · 2023Article
- De novo mitochondrial genome sequencing of Cladonia subulata and phylogenetic analysis with other dissimilar species.PloS one · 2023Article
- Discovery and excavation of lichen bioactive natural products.Frontiers in microbiology · 2023Review
- Chronicle of Research into Lichen-Associated Bacteria.Microorganisms · 2022Review
- Beyond Soil-Dwelling Actinobacteria: Fantastic Antibiotics and Where to Find Them.Antibiotics (Basel, Switzerland) · 2022Review
- Diversity of endophytic bacterial and fungal microbiota associated with the medicinal lichenFrontiers in microbiology · 2022Article
- Choosing the Right Life Partner: Ecological Drivers of Lichen Symbiosis.Frontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Lichens have been widely used in traditional medicine, especially by indigenous communities worldwide. However, their slow growth and difficulties in the isolation of lichen symbionts and associated microbes have hindered the pharmaceutical utilisation of lichen-produced compounds. Advances in high-throughput sequencing techniques now permit detailed investigations of the complex microbial communities formed by fungi, green algae, cyanobacteria, and other bacteria within the lichen thalli. Here, we used amplicon sequencing, shotgun metagenomics, and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.